Ironwood Pharmaceuticals (IRWD) Other financing activities (2016 - 2026)
Ironwood Pharmaceuticals' Other financing activities history spans 13 years, with the latest figure at $118000.0 for Q4 2025.
- On a quarterly basis, Other financing activities rose 31.11% to $118000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $213000.0, a 90.52% decrease, with the full-year FY2025 number at $213000.0, down 90.52% from a year prior.
- Other financing activities hit $118000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $1000.0 in the prior quarter.
- Over the last five years, Other financing activities for IRWD hit a ceiling of $17.5 million in Q4 2021 and a floor of -$8.7 million in Q3 2024.
- Historically, Other financing activities has averaged $2.5 million across 5 years, with a median of $1.4 million in 2022.
- Biggest five-year swings in Other financing activities: soared 887.76% in 2021 and later plummeted 66676.92% in 2024.
- Tracing IRWD's Other financing activities over 5 years: stood at $17.5 million in 2021, then tumbled by 70.44% to $5.2 million in 2022, then plummeted by 66.85% to $1.7 million in 2023, then plummeted by 94.74% to $90000.0 in 2024, then soared by 31.11% to $118000.0 in 2025.
- Business Quant data shows Other financing activities for IRWD at $118000.0 in Q4 2025, $1000.0 in Q3 2025, and $88000.0 in Q2 2025.